Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment Management

Valid: July 7, 2023 through July 6, 2024 Provider Statement This continuing education activity is provided by  Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Activity Description Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that is characterized by inflammation …

Evolution of Progression: An Expert Forum on Advancement in Monitoring and Treating Multiple Sclerosis

Release Date: 11/3/22 Expiration Date: 11/3/23 Activity Overview Advancements in the understanding of the pathophysiological mechanisms underlying multiple sclerosis (MS) have surged in recent years including increasing recognition that brain damage and subsequent disease worsening may occur earlier and more subtly than previously recognized. To date, there is no consensus regarding the relative roles of …

IJMSC: Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population

Release Date: April 1, 2022 Valid for Credit through: April 1, 2023 Activity Available Online: To access the article, post-test, and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, pharmacists, and other health care providers involved in the management of patients with multiple …

MedEd Talks Neurology Podcasts

The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options combined with the longevity and variable disease course of MS has led to the need to consider additional factors, such as safety, convenience, care during COVID-19, …

Fundamentals of Multiple Sclerosis Care – Part 1: Diagnosing the Disease and Managing Specific Populations

Release date: February 1, 2022 Valid through: January 31, 2024 Estimated Time to Complete Activity: 2 hours, 45 minutes Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, dietitians, researchers, advocates, and other members of the healthcare team involved …

Fundamentals of Multiple Sclerosis Care – Part 2: Diagnosing the Disease and Managing Specific Populations

Release date: February 1, 2022 Valid through: January 31, 2024 Estimated Time to Complete Activity: 2 hours, 15 minutes Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, dietitians, researchers, advocates, and other members of the healthcare team involved …

Fundamentals of Multiple Sclerosis Care – Part 3: Current and Emerging Therapies and Symptom Management

Release date: February 1, 2022 Valid through: January 31, 2024 Estimated Time to Complete Activity: 2 hours, 30 minutes Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, dietitians, researchers, advocates, and other members of the healthcare team involved …

Fundamentals of Multiple Sclerosis Care – Part 4: Current and Emerging Therapies and Symptom Management

Release date: February 1, 2022 Valid through: January 31, 2024 Estimated Time to Complete Activity: 2 hours, 30 minutes Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, dietitians, researchers, advocates, and other members of the healthcare team involved …